Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Design Therapeutics, Inc. (DSGN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues   [+]0.00.00.21.7
            Revenue growth   -100.0%-86.3% 
Cost of goods sold  0.00.00.02.7
Gross profit  0.00.00.2-1.1
            Gross margin    100.0%-65.8%
Selling, general and administrative   [+]19.011.12.51.1
Research and development  48.624.86.1 
Other operating expenses     -0.3
EBITDA   [+]-67.2-35.7-8.3 
            EBITDA margin    -3683.6%-115.4%
Depreciation and amortization  0.40.10.0 
EBIT   [+]-67.6-35.8-8.3-1.9
            EBIT margin    -3685.8%-115.4%
Other income (expense), net  4.30.30.1-0.1
Pre-tax income  -63.3-35.5-8.3-2.0
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -63.3-35.5-8.3-2.0
            Net margin    -3663.7%-123.8%
   
Basic EPS   [+]($1.14)($0.77)($0.52)($0.13)
Diluted EPS   [+]($1.14)($0.77)($0.52)($0.13)
   
Shares outstanding (basic)   [+]55.745.915.815.5
Shares outstanding (diluted)   [+]55.745.915.815.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy